All posts tagged: Schrodinger

“The Most Intelligent Photo Ever Taken”: The 1927 Solvay Council Conference, Featuring Einstein, Bohr, Curie, Heisenberg, Schrödinger & More

“The Most Intelligent Photo Ever Taken”: The 1927 Solvay Council Conference, Featuring Einstein, Bohr, Curie, Heisenberg, Schrödinger & More

A curi­ous thing hap­pened at the end of the 19th cen­tu­ry and the dawn­ing of the 20th. As Euro­pean and Amer­i­can indus­tries became increas­ing­ly con­fi­dent in their meth­ods of inven­tion and pro­duc­tion, sci­en­tists made dis­cov­ery after dis­cov­ery that shook their under­stand­ing of the phys­i­cal world to the core. “Researchers in the 19th cen­tu­ry had thought they would soon describe all known phys­i­cal process­es using the equa­tions of Isaac New­ton and James Clerk Maxwell,” Adam Mann writes at Wired. But “the new and unex­pect­ed obser­va­tions were destroy­ing this rosy out­look.” These obser­va­tions includ­ed X‑rays, the pho­to­elec­tric effect, nuclear radi­a­tion and elec­trons; “lead­ing physi­cists, such as Max Planck and Wal­ter Nernst believed cir­cum­stances were dire enough to war­rant an inter­na­tion­al sym­po­sium that could attempt to resolve the sit­u­a­tion.” Those sci­en­tists could not have known that over a cen­tu­ry lat­er, we would still be star­ing at what physi­cist Dominic Wal­li­man calls the “Chasm of Igno­rance” at the edge of quan­tum the­o­ry. But they did ini­ti­ate “the quan­tum rev­o­lu­tion” in the first Solvay Coun­cil, in Brus­sels, named for wealthy …

Schrodinger to offer Eli Lilly’s AI drug discovery platform on its software

Schrodinger to offer Eli Lilly’s AI drug discovery platform on its software

Jan 9 : Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major’s AI-based platform, TuneLab, on its drug designing software. Integration of Lilly’s TuneLab into Schrodinger’s LiveDesign will give biotech companies direct access to the artificial intelligence platform to help speed up ‌drug development, the biotech software maker said. Schrodinger’s cloud-based ‌platform, LiveDesign, helps chemists design compounds and predict the properties such as absorption and distribution of the experimental drug, helping them understand how a drug will behave in the body. Drug developers are increasing adoption of AI for discovery and safety testing ‍to get faster and cheaper results, in line with an FDA push to reduce animal testing in the near future. Current LiveDesign clients will be able to use TuneLab in the first quarter of ​this year, while the AI ‌software will be available to new users by the second quarter, Schrodinger’s Chief Strategy Officer Karen Akinsanya said. Lilly ​launched TuneLab, an AI and machine learning platform, last year to ⁠provide biotech companies access to ‌drug discovery …